CIC Events
This activity is part of the CLU-2023-2-01 initiative (Escalera de Excelencia), funded by the Department of Education of the Junta de Castilla y León and the European Regional Development Fund (FEDER)
05/03/2026
Immune dysregulation in monoclonal gammopathy and its implications for disease control and progression
Oihane Pérez Escurza — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca)
11/03/2026
RNA-binding proteins and translational control in cancer
Fátima Gebauer Hernández — Centre for Genomic Regulation (CRG, Barcelona, Spain)
13/03/2026
Defensa de tesis doctoral: Papel de la señalización RAS–PI3K en la regulación del fenotipo y la función de los fibroblastos asociados a cáncer
Marta Alcón Pérez — Programa de doctorado Biología y Clínica del Cáncer
26/03/2026
The Rho GTPase Network in anaplastic large cell lymphoma: From Lymphomagenesis to Therapeutic Targeting.
Claudia Voena — University of Torino, Italy
16/04/2026
ZMYM3 and ZNF292 mutations in chronic lymphocytic leukemia: clinical and biological implications
Alberto Rodríguez Sánchez — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca)
30/04/2026
A portfolio of immunotherapies to treat ALK+ cancers
Roberto Chiarle — Department of Pathology (Boston Children's Hospital)
Past Events
19/02/2026
Proteomic approaches for disentangling oncogenic kinase signalling and for advancing personalized therapies
Pedro Rodríguez Cutillas — Instituto de Parasitología y Biomedicina López-Neyra (CSIC), Granada
12/02/2026
Targeted Replacement of the NKG2A Checkpoint with CARs at the KLRC1 Locus Enhances NK Cell Immunotherapy in AML
Asunción Borrego Borrego — Centro de Investigación del Cáncer (Universidad de Salamanca-CSIC)